Nasdaq
Hong Kong-Based Prenetics to go Public via SPAC
The company recently launched a point-of-care and at-home rapid health monitoring system for infectious diseases.
SeqLL to Go Public in $13M IPO
The company, which was founded in 2013 to continue offering a sequencing technology developed by Helicos BioSciences, withdrew a planned IPO last year.
Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO
The firm offered 15,870,000 shares of its common stock, including 2,070,000 shares sold pursuant to the full exercise of the underwriters' option.
Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring
The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing.
Lucira Health Files for $115M IPO
The company, which is developing instrument-free, low-cost molecular diagnostics platform for infectious disease testing, plans to float its shares on the Nasdaq.
Sep 11, 2020
10x Genomics Prices Upsized $440M Public Offering
Aug 25, 2020
Berkeley Lights Q2 Revenues Fall 10 Percent
Jul 17, 2020
Berkeley Lights Prices Upsized $178.2M IPO
Jun 19, 2020
Genetron Health Prices $256M US IPO
Jun 16, 2020
Progenity Eyes $122.6M in Amended IPO
Jun 15, 2020
Genetron Health Targeting $175.5M in Amended US IPO
May 11, 2020
10x Genomics Q1 Revenues Increase 34 Percent
Apr 27, 2020
SeqLL Withdraws Plans for $8M IPO
Apr 9, 2020
T2 Biosystems Receives Nasdaq Warning Letter
Nov 7, 2019
Centogene Prices US IPO at $14 per Share
Sep 13, 2019
Aug 28, 2019